Table 5. Utilities of Outcomes After Treatment of Trigeminal Neuralgia by MVD or SRS.

N/A = not appropriate

Description	Utility	SD	Ref
BNI I	1.0	N/A	Hunink 2001 [21]
BNI II	0.871	0.213	Perez et al. 2009 [77]
BNI III	0.739	0.221	Perez et al. 2009 [77], Spatz et al. 2007 [78]
BNI IV-V	0.399	0.189	Perez et al. 2009 [77]
Complications after MVD	0.958	0.013	Calculated from analysis (Table 7)
Complications after SRS	0.962	0.085	Calculated from analysis (Table 8)
Needing to take medication	0.881	0.003	Calculated from analysis (Table 9)
Re-treatment by MVD	0.915*(utility MVD)	N/A	Lega et al. 2010 [79]
Re-treatment by SRS	0.915*(utility SRS)	N/A	Lega et al. 2010 [79]